TipRanks
Advertisement
Advertisement

GB:SYNC Stock Latest News

Syncona’s Beacon Therapeutics hits pivotal XLRP trial milestone, marking key value inflection
Company AnnouncementsSyncona’s Beacon Therapeutics hits pivotal XLRP trial milestone, marking key value inflection
2d ago
Syncona shareholders approve all resolutions at 2026 AGM
PremiumCompany Announcements
Syncona shareholders approve all resolutions at 2026 AGM
1M ago
Syncona Highlights Portfolio Progress and Prepares for Key Value Milestones
PremiumCompany Announcements
Syncona Highlights Portfolio Progress and Prepares for Key Value Milestones
2M ago
Syncona Updates Total Voting Rights and Share Capital Structure
PremiumCompany Announcements
Syncona Updates Total Voting Rights and Share Capital Structure
2M ago
Syncona Issues New Shares Under Long‑Term Incentive Scheme
PremiumCompany Announcements
Syncona Issues New Shares Under Long‑Term Incentive Scheme
2M ago
Syncona Publishes 2026 Annual Report and Sets August AGM
PremiumCompany AnnouncementsSyncona Publishes 2026 Annual Report and Sets August AGM
3M ago
Syncona Director Increases Stake with Share Purchase on London Stock Exchange
Premium
Company Announcements
Syncona Director Increases Stake with Share Purchase on London Stock Exchange
3M ago
Syncona Sets £250m Return Target as Portfolio Advances to Late-Stage Trials
Premium
Company Announcements
Syncona Sets £250m Return Target as Portfolio Advances to Late-Stage Trials
3M ago
Syncona appoints veteran investment specialist Norman Crighton to board
PremiumCompany Announcements
Syncona appoints veteran investment specialist Norman Crighton to board
3M ago
Syncona Wins Shareholder Backing for New Investment Policy and Board Refresh
PremiumCompany Announcements
Syncona Wins Shareholder Backing for New Investment Policy and Board Refresh
7M ago
Syncona’s Quell Therapeutics Advances Lead CAR-Treg Autoimmune Therapy and Refocuses Pipeline
PremiumCompany Announcements
Syncona’s Quell Therapeutics Advances Lead CAR-Treg Autoimmune Therapy and Refocuses Pipeline
7M ago
Syncona Refines Investment Strategy and Incentives Ahead of Shareholder Vote
PremiumCompany Announcements
Syncona Refines Investment Strategy and Incentives Ahead of Shareholder Vote
7M ago
Syncona Posts Strong Q3 NAV Gains as Beacon Financing and Late‑Stage Pipeline Drive Outlook
PremiumCompany AnnouncementsSyncona Posts Strong Q3 NAV Gains as Beacon Financing and Late‑Stage Pipeline Drive Outlook
8M ago
Syncona Ups Beacon Therapeutics Stake as Gene Therapy Group Raises $75m Series C
Premium
Company Announcements
Syncona Ups Beacon Therapeutics Stake as Gene Therapy Group Raises $75m Series C
9M ago
Syncona Limited Announces Total Voting Rights Update
Premium
Company Announcements
Syncona Limited Announces Total Voting Rights Update
10M ago
Syncona Limited to Issue New Shares Under Incentive Scheme
PremiumCompany Announcements
Syncona Limited to Issue New Shares Under Incentive Scheme
10M ago
Syncona Limited Reports Interim Results, Positions for Growth in Biotech Sector
PremiumCompany Announcements
Syncona Limited Reports Interim Results, Positions for Growth in Biotech Sector
10M ago
Syncona Highlights Autolus Therapeutics’ Q3 2025 Financial Performance and Strategic Growth
PremiumCompany Announcements
Syncona Highlights Autolus Therapeutics’ Q3 2025 Financial Performance and Strategic Growth
10M ago
Syncona Unveils Strategic Update to Maximize Shareholder Value
PremiumCompany Announcements
Syncona Unveils Strategic Update to Maximize Shareholder Value
11M ago
Beacon Therapeutics’ Gene Therapy Shows Promise in Phase 2 Trials for XLRP
PremiumCompany AnnouncementsBeacon Therapeutics’ Gene Therapy Shows Promise in Phase 2 Trials for XLRP
1y ago
Autolus Therapeutics Reports Q2 2025 Results and Advances Clinical Trials
Premium
Company Announcements
Autolus Therapeutics Reports Q2 2025 Results and Advances Clinical Trials
1y ago
Syncona Limited Reports Strong Clinical Progress and Strategic Milestones in Q1 2025
Premium
Company Announcements
Syncona Limited Reports Strong Clinical Progress and Strategic Milestones in Q1 2025
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >